1. Home
  2. VSTM vs MAGN Comparison

VSTM vs MAGN Comparison

Compare VSTM & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • MAGN
  • Stock Information
  • Founded
  • VSTM 2010
  • MAGN 1864
  • Country
  • VSTM United States
  • MAGN United States
  • Employees
  • VSTM N/A
  • MAGN N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • MAGN Paper
  • Sector
  • VSTM Health Care
  • MAGN Basic Materials
  • Exchange
  • VSTM Nasdaq
  • MAGN Nasdaq
  • Market Cap
  • VSTM 425.9M
  • MAGN 442.9M
  • IPO Year
  • VSTM 2012
  • MAGN N/A
  • Fundamental
  • Price
  • VSTM $4.17
  • MAGN $12.12
  • Analyst Decision
  • VSTM Strong Buy
  • MAGN Hold
  • Analyst Count
  • VSTM 9
  • MAGN 1
  • Target Price
  • VSTM $12.63
  • MAGN $16.00
  • AVG Volume (30 Days)
  • VSTM 2.6M
  • MAGN 1.0M
  • Earning Date
  • VSTM 08-07-2025
  • MAGN 08-15-2025
  • Dividend Yield
  • VSTM N/A
  • MAGN N/A
  • EPS Growth
  • VSTM N/A
  • MAGN N/A
  • EPS
  • VSTM N/A
  • MAGN N/A
  • Revenue
  • VSTM $10,000,000.00
  • MAGN $2,636,000,000.00
  • Revenue This Year
  • VSTM $129.06
  • MAGN $47.87
  • Revenue Next Year
  • VSTM $306.32
  • MAGN $4.76
  • P/E Ratio
  • VSTM N/A
  • MAGN N/A
  • Revenue Growth
  • VSTM N/A
  • MAGN 15.87
  • 52 Week Low
  • VSTM $2.10
  • MAGN $11.43
  • 52 Week High
  • VSTM $9.10
  • MAGN $26.78
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 25.74
  • MAGN N/A
  • Support Level
  • VSTM $4.43
  • MAGN N/A
  • Resistance Level
  • VSTM $6.62
  • MAGN N/A
  • Average True Range (ATR)
  • VSTM 0.30
  • MAGN 0.00
  • MACD
  • VSTM -0.16
  • MAGN 0.00
  • Stochastic Oscillator
  • VSTM 4.20
  • MAGN 0.00

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

Share on Social Networks: